Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: Importance of dose, species and drug

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1487-1498

  Mccann, Una D ^a   Yuan, Jie ^b   Hatzidimitriou, George ^b   Ricaurte, George A ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FENFLURAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SPECIES DIFFERENTIATION;

ANIMALS; ANOREXIA; BRAIN; FENFLURAMINE; MALE; MICE; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0030978891     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. APPEL, N. M., CONTRERA, J. F. AND DE SOUZA, E. B.: Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: Evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther. 249: 928-943, 1990.
2. BAUMGARTEN, G., GARATTINI, S., LORENS, S. AND WURTMAN, R.: Dexfenfluramine and neurotoxicity. Lancet 339: 359-360, 1992.
3. BONANNO, G., FASSIO, A., SEVERI, P., RUELLE, A. AND RAITERI, M.: Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J. Neurochem. 63: 1163 -1166, 1994.
4. CACCIA, S., ANELI, M., FERRRESE, A., FRACASO, C. AND GARATTINI, S.: The role of d-norfenfluramine in the indole-depleting effect of fenfluramine. Eur. J. Pharmacol. 233: 71-77, 1993.
5. CLINESCHMIDT, B., ZACHEI., A., TOTARO, J., PFLUEGER, A. AND McGUFFIN, J.: Fenfluramine and brain serotonin. Ann. N.Y. Acad. Sci. 305: 222-241, 1978.
6. DEROME-TREMBLAY, M. AND NATHAN, C.: Fenfluramine studies. Science 243: 991, 1989.
7. FISCHER, C. A., HATZIDIMITRIOU, G., KATZ, J. L. AND RICAURTE, G. A.: Reorganization of ascending serotonin axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine. J. Neurosci. 15: 5476-85, 1995.
8. FITZGERALD, J. AND REID, J.: Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices. Eur. J. Pharmacol. 191: 217-220, 1990.
9. FULLER, R. W. AND MOLLOY, B. B.: Recent studies with 4-chloroamphetamine and some analogues. Adv. Biochem. Psychopharm. 10: 195-205, 1974.
10. FULLER, R. W.: Basic advances in serotonin pharmacology. J. Clin. Psychiatry 53: 36-45, 1992.
11. FUXE, K., HAMBERGER, B., FARBEBO, L. AND OGREN, S.: On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptomine neurons, and their relation to the anorectic action of fenfluramine. Postgrad. Med. J. 51: 35-45, 1975.
12. GARATTINI, S., JORI, A., BUCZKO, W. AND SAMANIN, R.: The mechanism of action of fenfluramine. Postgrad. Med. J. 51: 27-35, 1975.
13. GARATTIM, S., CACCIA, S., MENNINI, T., SAMANIN, R., CONSOLO, S. AND LADINSKI, H.: Biochemical pharmacology of the anorectic drug fenfluramine - A Review. Curr. Med. Res. Opin. 6: 15-27, 1979.
14. 3H] 5-hydroxytryptophan induced by d-fenfluramine in rat hippocampal synaptosomes, Eur. J. Pharmocol. 238: 6-17, 1993.
15. HARVEY, J. AND McMASTER S.: Fenfluramine: Evidence for a neurotoxic action on midbrain and a long-term depletion of serotonin" Psychopharmacol. Comm. 1: 217-228, 1975.
16. HARVEY, J., MCMASTER S. AND FULLER, R.: Comparison between the neurotoxic and serotonin depleting effects of various halogenated derivatives of amphetamine in the rat. J. Pharmacol. Exp. Ther. 202: 581-589, 1977.
17. HEKMATPANAH, C. R. AND PEROUTKA, S. J.: 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Eur. J. Pharmacol. 177: 95-100, 1990.
18. JOHNSON, M. P. AND NICHOLS, D. E.: Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine. Pharmacol. Biochem. Behav. 36: 105-109, 1990.
19. KALIA, M.: Dexfenfluramine and neurotoxicity. Lancet 339: 360, 1992.
20. KLEVEN, M. S. AND SEIDEN, L. S.: D-,L-, DL-fenfluramine cause long lasting depletions of serotonin in rat brain. Brain Res. 505: 351-353, 1989.
21. KLEVEN, M. S., SCHUSER, C. R. AND SEIDEN, L. S.: Effects of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J. Pharmacol. Exp. Ther. 246: 822-828, 1988.
22. KREISS, D. AND LUCKI, I.: The presence of a serotonin reuptake inhibitor alters pharmacologic manipulations of serotonin release. Neuroscience 52: 295-301, 1993.
23. MAURA, G., GEMIGNANI, A., VERSAGE, P., MARTIRE, M. AND RAITERI, M.: Carrier-mediated and carrier independent release of serotonin from isolated central nerve endings. Neurochem. Int. 4: 219-224, 1982.
24. MCCANN, U. D. AND RICAURTE, G. A.: Subjective and neurotoxic effects of ( ±3,4)-methylenedioxymethamphetamine (MDMA, "ecstasy") are separable: Clinical evidence. J. Clin. Psychopharmacol. 13: 214-217, 1993.
25. MCCANN, U. D., HATZIDIMITRIOU, G., RIDENOUR, A., FISHER, C., KATZ , J. AND RICAURTE, G. A.: Dexfenfluramine neurotoxicity in humans: Further preclinical evidence that concern is warranted. J. Pharmacol. Exp. Ther. 269: 792-798, 1994.
26. MCCANN, U., YUAN, J. AND RICAURTE, G.: Fenfluramine's appetite suppression and serotonin neurotoxicity are separable. Eur. J. Pharmacol. 283: R5-R7. 1995.
27. MOLLIVER, D. C. AND MOLLIVER, M. E.: Anatomic evidence of a neurotoxic effect of (-) fenfluramine upon serotonergic projections in the rat. Brain Res. 511: 165-168, 1990.
28. RAITERI, M., BONNANO, G. AND VALLEBUONA, F.: In vitro and in vivo effects of d-fenfluramine: No apparent relation between 5-hydroxytryptamine release and hypophagia. J. Pharmacol. Exp. Ther. 273: 643-649, 1995.
29. RICAURTE, G. A., MARTELLO, A. L., KATZ, J. L. AND MARTELLO, M. B.: Lasting effects of (±)3,4-methylenedioxymethamphetamine on central serotonergic neurons in non-human primates: Neurochemical observations. J. Pharmacol. Exp. Ther. 261: 616-622, 1992.
30. ROWLAND, N. E. AND CARLTON, J.: Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol. 27: 13-62, 1986.
31. SABOL, K., RICHARDS, J. AND SEIDEN, L.: Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 585: 421-424, 1992.
32. SANDERS-BUSH, E., BUSHING, J. A. AND SULSER, F.: Long-term effects of p-chloro amphetamine and related drugs on central serotonergic mechanisms. J. Pharmacol. Exp. Ther. 192: 33-41, 1975.
33. 125I]RTI-55. Synapse 16: 263-268, 1994.
34. SCHMIDT, C. J.: Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240: 1-7, 1987.
35. SCHMIDT, C. J., LEVIN, J. A. AND LOVENBERG, W.: In vitro and In vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoamine systems in the rat brain. Biochem. Pharmacol. 36: 747-755, 1987.
36. SCHUSTER, C. R., LEWIS, M. AND SEIDEN, L.: Fenfluramine: Neurotoxicity. Psychopharmacol. Bull. 22: 148-151, 1986.
37. TRULSON, M. AND JACOBS, B.: Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur. J. Pharmacol. 36: 149-154, 1976.
38. WESTPHALEN, R. AND DODD, P.: The nature of D-L-induced 5-HT re-uptake transporter loss in rats. Mol. Neurobiol. 11: 165-175, 1995.
39. ZACZEK, R., BATTAGLIA, G., CULP, S., APPEL, N. M., CONTRERA, J. F. AND DE SOUZA, E. B.: Effects of repeated fenfluramine administration on indexes of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time-course data. J. Pharmacol. Exp. Ther. 253: 104-112, 1990.